SMAD3 and metabolic syndrome: Smad3-deficient mice are protected from diet-induced obesity and diabetes and Smad3 acts as a repressor of PGC-1α expression, thus suggesting a link between failure in mitochondrial biogenesis, metabolic syndrome, and liver fibrosis [102].